Bioequivalence of a Single Subcutaneous Dose of BEPO and REPO in Healthy Male Subjects
Clinical trial NCT02426151 · COMPLETED
Trial details
- NCT number
- NCT02426151
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2015-05-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.